SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-17-000071
Filing Date
2017-04-20
Accepted
2017-04-20 16:17:11
Documents
4
Period of Report
2017-04-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v3_ptcform8kxitem201xitem3.htm 8-K 45488
2 EXHIBIT 2.1 exhibit21_amendmentno1toas.htm EX-2.1 33774
3 EXHIBIT 99.1 a42017_exhibit991xpressrel.htm EX-99.1 23566
4 a42017exhibit991press_image1.jpg GRAPHIC 6428
  Complete submission text file 0001070081-17-000071.txt   113153
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 17773203
SIC: 2834 Pharmaceutical Preparations